Search

Sword & Shield Pharma

Sector: Healthcare | Industry: Drugs & Pharma
R 5.66 0.00  | 0.00% - - 2.92
BSE Price: Oct 18, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 18, 2019 5.66 0.00 0.00% 5.55 5.66 2,300 5.55 - 5.66
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 3,161 P/B: 58.05 NSE Code:
52-Week Range: R 2.36 - 7.45 Dividend Yield: 0.00% BSE Code: 531637
TTM EPS: R -0.19 Book Value: R 0.10 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Sword & Shield Pharma - -6.60 -21.61 - - - -
S&P BSE Small Cap -10.74 1.80 -3.18 -8.02 -0.38 4.94 5.38
S&P BSE Healthcare -9.25 -1.92 -2.85 -13.70 -8.12 -1.27 10.94
Company's return has been calculated on basis of BSE's price.
As on Oct 18, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -67.25 -71.31 -56.41
Net Profit 34.51 9.70 6.30
EPS 40.73 11.46 7.24
Book Value 226.55 51.01 -32.08
Average
Operating Margin -553.45 332,058.72 199,203.53
Net Margin -544.17 -263.12 -199.23
Return on Networth -590.36 -196.79 -150.99
Return on Investment -93.49 -40.42 -61.81
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -100.00 - -
Operating Profit -262.50 -31.82 -41.46
Net Profit -262.50 -31.82 -41.46
EPS -262.06 -31.85 -41.46
TTM
Revenue 0.00 300.00 -31.03
Operating Profit -16.87 33.10 39.38
Net Profit -16.87 33.10 39.38
EPS -16.87 33.07 41.62
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Sword & Shield Pharma 2.92 0.02 -0.10 -404.17 -590.36 58.05 -
Astrazeneca Pharma India 5,689.63 771.42 69.56 8.84 20.03 17.77 81.79
Eris Lifesciences 5,793.71 1,005.70 303.64 29.29 28.96 4.70 19.08
News & Announcements
Contact Information

Company: Sword & Shield Pharma Ltd.

Address: 55, World Business House, Near Parimal Garden, Ambawadi, Ahmedabad, Gujarat - 380006

Email: [email protected]

Website: www.swordnshieldpharma.com

Registrar & Transfer Agent: MCS Ltd

Address: 383, Lake Gardens, 1st Floor, Kolkata-700045 (old address: 12/1/5 Monoharpukur RoadKolkata-700 026), 383, Lake Gardens, 1st Floor, | Phone: 91-033-40724051-53 | Fax: 91-033-40724050

Email: [email protected]

Essential checks
Altman Z-Score
48.15
Piotroski F-Score
3
Modified C-Score
3
1-Year Price to Earnings
Not available
1-Year Price to Book
58.05
Earnings Yield
EBIT / Enterprise value
-3.46%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,278.35 -0.91%
Caplin Point Laboratories R396.85 +0.61%
Eris Lifesciences R422.60 +1.57%
FDC R160.90 -0.28%
JB Chemicals & Pharma R366.55 +2.03%
Laurus Labs R316.20 +1.92%
Strides Pharma Science R353.85 0.00%
Sun Pharma Adv. Research R132.50 +1.38%
Suven Life Sciences R280.55 +5.95%
Wockhardt R266.45 +2.80%
As on Oct 18, 15:59